This article highlights the benefits of Laparoscopic antireflux surgery (LARS) as an active treatment option for chronic cough related to gastroesophageal reflux disease, with three-quarters of patients having complete resolution of symptoms. Chronic cough is a challenging and possibly debilitating condition characterized by various underlying pathologies. Studies have shown that patient-reported prevalence is 1 in 10 individuals, presenting a substantial healthcare burden for its diagnosis and treatment.
The medical resources required for evaluation and the time needed to identify and treat the underlying etiologies pose a challenge in providing satisfactory quality of life to patients. In addition, the literature suggests that in as many as 50% of patients with chronic cough, reflux may be the key factor in intensifying the manifestations of other comorbidities. According to the WHO…
